Edaravone slows progression of ALS when started early on

VANCOUVER – The antioxidant edaravone was associated with less deterioration in functional rating and quality of life scales when started early in the course of amyotrophic lateral sclerosis (ALS),...

Source: Clinical Neurology News - June 14, 2016 Category: Neurology Source Type: news